Tarek Mouhieddine, MD(@tarekmd91) 's Twitter Profileg
Tarek Mouhieddine, MD

@tarekmd91

@AUB_Lebanon | @DanaFarber | @IcahnMountSinai | @SinaiHemeOnc Fellow @TischCancer | Physician-scientist #multiplemyeloma #myeloma #mmsm 🇱🇧🇺🇸

ID:385075225

linkhttps://www.linkedin.com/in/tarekmouhieddine calendar_today04-10-2011 20:39:40

1,2K Tweets

2,2K Followers

3,3K Following

Samer Al Hadidi, MD,MS,FACP(@HadidiSamer) 's Twitter Profile Photo

Genomic Classification and Individualized Prognosis in Multiple Myeloma Francesco Maura Ola Landgren, M.D. Journal of Clinical Oncology

ascopubs.org/doi/10.1200/JC…

Individualized risk in NDMM (IRMMa) model

Nice work building on GEP (UAMS) and current risk systems

Genomic Classification and Individualized Prognosis in Multiple Myeloma #mmsm @FrancescoMaura4 @DrOlaLandgren @JCO_ASCO ascopubs.org/doi/10.1200/JC… Individualized risk in NDMM (IRMMa) model Nice work building on GEP (UAMS) and current risk systems
account_circle
Miriam Merad, MD, PhD(@MiriamMerad) 's Twitter Profile Photo

Very excited by our results nature showing that IL4R signaling is strongly enriched in myeloid cells that infiltrate mice and lung cancer lesions nature.com/articles/s4158…

account_circle
Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽(@Rfonsi1) 's Twitter Profile Photo

One of the key findings of the IsKia trial is the differential effect on MRD, but at the level of 10-6 for very high-risk patients. Quads likely will benefit disproportionately this group (albeit not the full solution), and perhaps a threshold of 10-6 will better at…

One of the key findings of the IsKia trial is the differential effect on MRD, but at the level of 10-6 for very high-risk patients. Quads likely will benefit disproportionately this group (albeit not the full solution), and perhaps a threshold of 10-6 will better at…
account_circle
Muzaffar Qazilbash(@Transplant_Doc) 's Twitter Profile Photo

Inflammatory Biomarkers and Outcomes in Multiple Myeloma Patients after CAR T-Cell Therapy. Higher baseline fibrinogen and ferritin were associated with inferior OS; higher baseline ALC associated with more ICANS Tarek Mouhieddine, MD Joshua Richter ash.confex.com/ash/2023/webpr…

account_circle
Bruno A. Costa, MD(@mdbrunocosta) 's Twitter Profile Photo

How to write a review simple enough to elucidate MM CAR-T for students/early-career HCWs while satisfactorily providing the latest updates on the field for Hem/Onc peeps? Well, it’s not easy… But me and
Norah Sadek, MD tried: doi.org/10.1002/cpt.30…

Check out our state-of-the-art…

account_circle
The Tisch Cancer Institute(@TischCancer) 's Twitter Profile Photo

Mount Sinai Researchers Receive $7 Million to Improve Outcomes for High-risk Blood Cancer Patients From the Multiple Myeloma Research Foundation | Mount Sinai - New York shar.es/agX9Rx
Icahn School of Medicine at Mount Sinai Multiple Myeloma RF
Samir Parekh, MD; Brian Brown, PhD

account_circle
Daniel Nathan(@DNathanMD) 's Twitter Profile Photo

Excited to share our review of CH and inflammation covering clinical applications, pre-clinical mechanisms, and next steps in the field. Thanks to co-authors at Mount Sinai Hematology/Oncology Fellowship and The Tisch Cancer Institute. Online now Critical Reviews in Oncology Hematology (CROH).
sciencedirect.com/science/articl…

account_circle
Elio Adib(@adib_elio) 's Twitter Profile Photo

🚨Thrilled to share our latest work on the immune implications of MTAP deletions, out now Cancer Cell

cell.com/cancer-cell/fu…

🤝Result of a collaboration between Brigham and Women’s Research Dana-Farber UT Austin. Co-lead w/ Donjeta Gjuka & senior authors David Kwiatkowski & Everett Stone

🚨Thrilled to share our latest work on the immune implications of MTAP deletions, out now @Cancer_Cell cell.com/cancer-cell/fu… 🤝Result of a collaboration between @BrighamResearch @DanaFarber @UTAustin. Co-lead w/ Donjeta Gjuka & senior authors David Kwiatkowski & Everett Stone
account_circle
Tarek Mouhieddine, MD(@tarekmd91) 's Twitter Profile Photo

Congratulations to Dr. Sundar Jagannath The Tisch Cancer Institute Mount Sinai Health System Icahn School of Medicine at Mount Sinai for receiving the Waldenstrom Lifetime Achievement Award in myeloma. Myeloma Society
What an amazing journey and inspiring physician and human being!
Thank you for everything you do!

Congratulations to Dr. Sundar Jagannath @TischCancer @MountSinaiNYC @IcahnMountSinai for receiving the Waldenstrom Lifetime Achievement Award in myeloma. @Myeloma_Society #IMS23 What an amazing journey and inspiring physician and human being! Thank you for everything you do!
account_circle
Rafael Fonseca MD 🦔🇺🇸🏜🇲🇽(@Rfonsi1) 's Twitter Profile Photo

Very interesting work being presented regarding the origin of myeloma cells. Could they be earlier B cells? Very courageous research to try to address- but I would still have to see more. Particularly given switch translocations in IgH MM

account_circle